We presume that this mechanism similarly occurs in AD, by which the increased IL-17 and IL-22 in peripheral blood promotes BBB disruption that allows more Th17 cells to migrate into brain parenchyma to produce more IL-17 and IL-22 in the brain. This evidence concerns the gene IL22 and Alzheimer disease.